NurExone Total Assets vs Total Cash From Operating Activities Analysis
| NRX Stock | 0.71 0.01 1.43% |
NurExone Biologic financial indicator trend analysis is infinitely more than just investigating NurExone Biologic recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NurExone Biologic is a good investment. Please check the relationship between NurExone Biologic Total Assets and its Total Cash From Operating Activities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NurExone Biologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Total Assets vs Total Cash From Operating Activities
Total Assets vs Total Cash From Operating Activities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NurExone Biologic Total Assets account and Total Cash From Operating Activities. At this time, the significance of the direction appears to have strong relationship.
The correlation between NurExone Biologic's Total Assets and Total Cash From Operating Activities is 0.67. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Cash From Operating Activities in the same time period over historical financial statements of NurExone Biologic, assuming nothing else is changed. The correlation between historical values of NurExone Biologic's Total Assets and Total Cash From Operating Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of NurExone Biologic are associated (or correlated) with its Total Cash From Operating Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Cash From Operating Activities has no effect on the direction of Total Assets i.e., NurExone Biologic's Total Assets and Total Cash From Operating Activities go up and down completely randomly.
Correlation Coefficient | 0.67 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Assets
Total assets refers to the total amount of NurExone Biologic assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NurExone Biologic books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Cash From Operating Activities
Most indicators from NurExone Biologic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NurExone Biologic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NurExone Biologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Selling General Administrative is likely to climb to about 2.7 M in 2024. Issuance Of Capital Stock is likely to climb to about 1.4 M in 2024
| 2010 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 1.7M | 5.5M | 3.7M | 4.0M | Research Development | 573K | 1.4M | 1.5M | 1.3M |
NurExone Biologic fundamental ratios Correlations
Click cells to compare fundamentals
NurExone Biologic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NurExone Stock Analysis
When running NurExone Biologic's price analysis, check to measure NurExone Biologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NurExone Biologic is operating at the current time. Most of NurExone Biologic's value examination focuses on studying past and present price action to predict the probability of NurExone Biologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NurExone Biologic's price. Additionally, you may evaluate how the addition of NurExone Biologic to your portfolios can decrease your overall portfolio volatility.